国产精品毛片VA无遮挡,精品国产日本在线观看,久久久久久久久国产精品,日本欧美一区人妻中文字幕

掃碼關(guān)注公眾號(hào)           掃碼咨詢技術(shù)支持           掃碼咨詢技術(shù)服務(wù)
  
客服熱線:400-901-9800  客服QQ:4009019800  技術(shù)答疑  技術(shù)支持  質(zhì)量反饋  人才招聘  關(guān)于我們  聯(lián)系我們
欧美黄片在线高清视频,欧美日本高清在线观看,亚洲精品欧美日韩在线
Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293) (bs-43078P)
訂購熱線:400-901-9800
訂購郵箱:sales@m.hebaili.cn
訂購QQ:  400-901-9800
技術(shù)支持:techsupport@m.hebaili.cn
說明書: 100ug  500ug  
100ug/4880.00元
500ug/15800.00元
大包裝/詢價(jià)

產(chǎn)品編號(hào) bs-43078P
英文名稱 Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293)
中文名稱 重組SARS冠狀病毒2 奧密克戎突變體蛋白Spike RBD
別    名 Recombinant SARS-Cov-2 (Omicron, B.1.1.529) Spike RBD protein (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), C-His (HEK293)   重組SARS冠狀病毒2 奧密克戎突變體蛋白Spike RBD(G339D、S371L、S373P、S375F、K417N、N440K、G446S、S477N、T478K、E484A、Q493R、G496S、Q498R、N501Y、Y505H) ; 奧密克戎(B.1.1.529);
理論分子量 26.9kDa
檢測(cè)分子量 36
性    狀 Lyophilized or Liquid
濃    度 >0.5 mg/ml
物    種 SARS-Cov-2
序    列 319-537/1273
純    度 >90% as determined by SDS-PAGE
純化方法 AC
內(nèi)毒素 Not analyzed
表達(dá)系統(tǒng) HEK293 cell
活性 Not tested
標(biāo)簽 C-His
緩 沖 液 PBS (pH7.4).
保存條件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
注意事項(xiàng) This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.

產(chǎn)品圖片
Measured by its binding ability in a functional ELISA. Immobilized human ACE2, His-Avi Tag (Cat: bs-46001P) at 2μg/mL (100 μL/Well) can bind SARS-CoV-2 Spike RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H), His Tag (Cat: bs-43078P), the EC50 is 187ng/mL.
The purity of the protein is greater than 90% as determined by reducing SDS-PAGE.
版權(quán)所有 2004-2026 www.m.hebaili.cn 北京博奧森生物技術(shù)有限公司
通過國(guó)際質(zhì)量管理體系ISO 9001:2015 GB/T 19001-2016    證書編號(hào): 00124Q34771R2M/1100
通過國(guó)際醫(yī)療器械-質(zhì)量管理體系ISO 13485:2016 GB/T 42061-2022    證書編號(hào): CQC24QY10047R0M/1100
京ICP備05066980號(hào)-1         京公網(wǎng)安備110107000727號(hào)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |